Company news

January 7, 2013
Back to TopE-mailPrintBookmark and Share

Indianapolis-based Eli Lilly and Co. and Germany-based Boehringer Ingelheim GmbH got good news from their Phase 3 trial of a new drug for patients with Type 2 diabetes, and said they plan to file for its market approval later this year. The drug, called empagliflozin, lowered diabetics’ levels of hemoglobin—a measure of blood sugar—more than a placebo. How the new drug will compare against similar drugs, called sodium glucose co-transporter-2 inhibitors, remains unclear. Lilly competitors Johnson & Johnson, Bristol-Myers Squibb Co. and AstraZeneca plc are racing to bring the new class of drugs to market. But Lilly and Boehringer officials said they are pleased enough with the results to file for a launch this year, according to a statement released Monday by Lilly. "We are pleased with the results for these Phase III clinical trials for empagliflozin," Enrique Conterno, president of Lilly's diabetes division, said in a prepared statement. "Diabetes is growing at a tremendous rate across the world. Patients and their physicians need more treatment options in order to help improve their blood sugar levels and reach their treatment goals." Also, Lilly and Boehringer Ingelheim announced that Lilly will re-assume exclusive development rights to a once-a-day insulin it calls LY2605541. That drug, as well as empagliflozin, were part of a co-development agreement Lilly and Boehringer signed in January 2011. Lilly unveiled a better-than-expected 2013 earnings forecast Friday, which sent its stock up by nearly 4 percent that day. The drugmaker forecast 2013 adjusted earnings of between $3.75 and $3.90 per share. Wall Street analysts were expecting 2013 earnings of $3.73 per share, according to a survey by FactSet.

The physician arm of Indianapolis-based hospital system Community Health Network took over cardiovascular services at Community Westview Hospital, displacing The Care Group LLC, on Jan. 1. Community Physician Network will now provide all specialty heart care at the 67-bed hospital at West 38th Street and North Guion Road. Community Health Network absorbed Westview in June 2011, securing a presence on the west side of Indianapolis to accompany its existing hospitals on the southern, eastern and northern sides of the metro area. The Care Group, one of the city’s largest physician practices, was acquired by Indianapolis-based hospital system St. Vincent Health in 2010. Community and St. Vincent are now working together to sign contracts with employers and health insurers in what they call an affordable care consortium.

A building on the northwest side of Indianapolis is the target of a foreclosure claiming that owner Women’s Physician Group LLP has defaulted on a $9 million loan. The lawsuit, filed Dec. 13 by U.S. Bank, claims that the physicians' group received the loan in April 2007 and stopped payment in August 2012, owing $8.7 million in principal. Including penalties and fees, though, U.S. Bank is seeking nearly $10.5 million, according to the suit. The 33,617-square-foot building at 8081 Township Line Road is completely occupied, according to the website of Cornerstone Companies Inc., the building’s broker. A representative of the physician group could not be reached for comment.


Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ
  1. If I were a developer I would be looking at the Fountain Square and Fletcher Place neighborhoods instead of Broad Ripple. I would avoid the dysfunctional BRVA with all of their headaches. It's like deciding between a Blackberry or an iPhone 5s smartphone. BR is greatly in need of updates. It has become stale and outdated. Whereas Fountain Square, Fletcher Place and Mass Ave have become the "new" Broad Ripples. Every time I see people on the strip in BR on the weekend I want to ask them, "How is it you are not familiar with Fountain Square or Mass Ave? You have choices and you choose BR?" Long vacant storefronts like the old Scholar's Inn Bake House and ZA, both on prominent corners, hurt the village's image. Many business on the strip could use updated facades. Cigarette butt covered sidewalks and graffiti covered walls don't help either. The whole strip just looks like it needs to be power washed. I know there is more to the BRV than the 700-1100 blocks of Broad Ripple Ave, but that is what people see when they think of BR. It will always be a nice place live, but is quickly becoming a not-so-nice place to visit.

  2. I sure hope so and would gladly join a law suit against them. They flat out rob people and their little punk scam artist telephone losers actually enjoy it. I would love to run into one of them some day!!

  3. Biggest scam ever!! Took 307 out of my bank ac count. Never received a single call! They prey on new small business and flat out rob them! Do not sign up with these thieves. I filed a complaint with the ftc. I suggest doing the same ic they robbed you too.

  4. Woohoo! We're #200!!! Absolutely disgusting. Bring on the congestion. Indianapolis NEEDS it.

  5. So Westfield invested about $30M in developing Grand Park and attendance to date is good enough that local hotel can't meet the demand. Carmel invested $180M in the Palladium - which generates zero hotel demand for its casino acts. Which Mayor made the better decision?